These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

12762 related articles for article (PubMed ID: 11496947)

  • 1. Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors.
    Hanes J; Sills A; Zhao Z; Suh KW; Tyler B; DiMeco F; Brat DJ; Choti MA; Leong KW; Pardoll DM; Brem H
    Pharm Res; 2001 Jul; 18(7):899-906. PubMed ID: 11496947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
    Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
    Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma.
    Hsu W; Lesniak MS; Tyler B; Brem H
    J Neurooncol; 2005 Sep; 74(2):135-40. PubMed ID: 16193383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
    Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
    J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.
    Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H
    Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
    DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
    J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system.
    Ewend MG; Thompson RC; Anderson R; Sills AK; Staveley-O'Carroll K; Tyler BM; Hanes J; Brat D; Thomas M; Jaffee EM; Pardoll DM; Brem H
    J Immunother; 2000; 23(4):438-48. PubMed ID: 10916753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of particulate systems supporting tumor cell fractions in a preventive vaccination against intracranial rat glioma.
    Sapin A; Clavreul A; Garcion E; Benoit JP; Menei P
    J Neurosurg; 2006 Nov; 105(5):745-52. PubMed ID: 17121138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma.
    Glick RP; Lichtor T; Mogharbel A; Taylor CA; Cohen EP
    Neurosurgery; 1997 Oct; 41(4):898-906; discussion 906-7. PubMed ID: 9316052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
    Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
    J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2.
    Iwadate Y; Namba H; Sakiyama S; Yamaura A; Tagawa M
    Int J Mol Med; 2002 Dec; 10(6):741-7. PubMed ID: 12430001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
    Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors.
    Emerich DF; Winn SR; Snodgrass P; LaFreniere D; Agostino M; Wiens T; Xiong H; Bartus RT
    Pharm Res; 2000 Jul; 17(7):776-81. PubMed ID: 10990194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release.
    Buahin KG; Brem H
    J Neurooncol; 1995 Nov; 26(2):103-10. PubMed ID: 8787852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-mediated therapy of intracranial brain tumors in a rat model.
    Sharma US; Sharma A; Chau RI; Straubinger RM
    Pharm Res; 1997 Aug; 14(8):992-8. PubMed ID: 9279878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
    Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone mediated inhibition of local IL-2 immunotherapy is dose dependent in experimental brain tumors.
    Lesniak MS; Gabikian P; Tyler BM; Pardoll DM; Brem H
    J Neurooncol; 2004 Oct; 70(1):23-8. PubMed ID: 15527103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
    Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 639.